Table 2.
79 putative targets of XBCQD for the treatment of COVID-19
No. | Gene | No. | Gene | No. | Gene | No. | Gene |
---|---|---|---|---|---|---|---|
1 | ACE2 | 21 | LGALS3 | 41 | CCL5 | 61 | GAPDH |
2 | DPP4 | 22 | F3 | 42 | MAPK3 | 62 | PRKCE |
3 | CTSL | 23 | ABO | 43 | PARP1 | 63 | F10 |
4 | IL6 | 24 | JAK1 | 44 | BAX | 64 | PRKCA |
5 | CTSB | 25 | SREBF2 | 45 | BCL2 | 65 | APOBEC3G |
6 | COMT | 26 | TNF | 46 | PIK3CA | 66 | GSK3A |
7 | PRKACA | 27 | TGFB1 | 47 | CASP8 | 67 | EIF4E |
8 | DNMT1 | 28 | NFκB1 | 48 | CDK2 | 68 | PTGS1 |
9 | PLAT | 29 | JAK2 | 49 | PTGS2 | 69 | TTR |
10 | POR | 30 | F2 | 50 | NOS2 | 70 | IGKC |
11 | CSNK2B | 31 | CASP3 | 51 | PIK3CB | 71 | LCK |
12 | IMPDH2 | 32 | MBL2 | 52 | MCL1 | 72 | LCN2 |
13 | POLA1 | 33 | IL1A | 53 | CREB1 | 73 | BCL2A1 |
14 | SIGMAR1 | 34 | IL2 | 54 | SIRT1 | 74 | CALM1 |
15 | SIRT5 | 35 | TLR7 | 55 | RELA | 75 | NAE1 |
16 | PRKAR2B | 36 | ADA | 56 | HSP90B1 | 76 | PRSS2 |
17 | AR | 37 | CSF2 | 57 | PIK3CG | 77 | PRKCB |
18 | IL1B | 38 | ANPEP | 58 | ACTB | 78 | ENPP1 |
19 | NOS3 | 39 | PPARG | 59 | GSK3B | 79 | HPGDS |
20 | CCL2 | 40 | TP53 | 60 | VCP |